Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Sep 28:8:85.
doi: 10.1186/1477-7819-8-85.

The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer

Affiliations
Comparative Study

The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer

Ozgur Kemik et al. World J Surg Oncol. .

Abstract

Background: Acute-phase response proteins (APRP), cytokines and hormones have been claimed to be an independent prognostic factor of malignancies, however the basis for their association with prognosis remains unexplained. We suggest that in colon malignancies, as similar to pancreatic and lung cancers, changes in APRP are associated with angiogenesis.

Methods: C-reactive protein (CRP), albumin, IL-1α, IL-1β, IL-6, IL-8, IL-10, TNF-α, midkine, VEGF-A, VEGF-C, leptin, adiponectin, and ghrelin serum levels are studied in 126 colon cancer patients and 36 healthy subjects.

Results: We found statistically significant difference and correlations between two groups. We found significantly higher serum CRP, IL-1α, IL-1β, IL-6, IL-8, IL-10, TNF-α, VEGF-A, VEGF-C and leptin concentrations in patients relative to controls (p < 0.001). We found lower levels of the serum albumin, midkine, adiponectin and ghrelin in patients compared to control subjects (p < 0.001).

Conclusions: Cachexia in patients with colon cancers is associated with changes in APRP, cytokines and hormone concentrations. These biomarkers and cachexia together have a direct relationship with accelerated angiogenesis. This may lead to a connection between the outcomes in malignancies and the biomarkers.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Loberg RD, Bradley DA, Tomlins SA, Chinnaiyan AM, Pienta KJ. The lethal phenotype of cancer: the molecular basis of death due to malignancy. CA Cancer J Clin. 2007;57:225 241. doi: 10.3322/canjclin.57.4.225. - DOI - PubMed
    1. Polesty JA, Dudrick SJ. What we have learned about cachexia in gastrointestinalcancer. Dig Dis. 2003;21:198–213. doi: 10.1159/000073337. - DOI - PubMed
    1. Chamberlain JS. Cachexia in cancer-zeroing in onmyosin. N Engl J Med. 2004;351:2124–2125. doi: 10.1056/NEJMcibr042889. - DOI - PubMed
    1. Rubin H. Cancer cachexia: its correlations andcauses. Proc Natl Acad Sci USA. 2003;100:5384–5389. doi: 10.1073/pnas.0931260100. - DOI - PMC - PubMed
    1. Boddeart MS, Gerritsen WR, Pinedo HM. On our own way to targeted therapy for cachexia incancer. Curr Opin Oncol. 2006;18:335–340. doi: 10.1097/01.cco.0000228738.85626.ac. - DOI - PubMed

Publication types

MeSH terms